Cholesterol and total mortality: need for larger trials.

Cholesterol and total mortality: need for larger trials.

Bibliographic Details
Main Authors:	Collins, R, Keech, A, Peto, R, Sleight, P, Kjekshus, J, Wilhelmsen, L, MacMahon, S, Shaw, J, Simes, J, Braunwald, E
Format:	Journal article
Language:	English
Published:	1992

Similar Items

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
by: Chen, Z, et al.
Published: (1991)

Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
by: Keech, A, et al.
Published: (1994)

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
by: Yusuf, S, et al.
Published: (1988)

Efficacy and safety of cholesterol-lowering treatment - Reply
by: Baigent, C, et al.
Published: (2006)

Efficacy and safety of cholesterol-lowering treatment - Reply
by: Baigent, C, et al.
Published: (2006)

SERUM-CHOLESTEROL LEVELS AND STROKE MORTALITY
by: Chen, Z, et al.
Published: (1989)

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.
by: Collins, R, et al.
Published: (2001)

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
by: MacMahon, S, et al.
Published: (2001)

Cholesterol, statins, and mortality - Reply
by: Lewington, S, et al.
Published: (2008)

Stroke, coronary heart disease, cholesterol and blood pressure
by: Lewington, S, et al.
Published: (1997)

Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.
by: Lewington, S, et al.
Published: (1999)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
by: Kearney, P, et al.
Published: (2008)

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.
by: Harris, M, et al.
Published: (1995)

Cholesterol, statins, and mortality - Authors' reply
by: Lewington, S, et al.
Published: (2008)

Blood pressure, cholesterol, and common causes ol death: A review
by: Lewington, S, et al.
Published: (1999)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl
by: Collins, R, et al.
Published: (2002)

Making randomised trials larger: a simple solution?
by: Gray, R, et al.
Published: (1995)

THE RELATIONS OF SERUM-CHOLESTEROL, BLOOD-PRESSURE, AND SMOKING HABIT TO CORONARY HEART-DISEASE IN A POPULATION WITH LOW MEAN CONCENTRATIONS OF SERUM-CHOLESTEROL
by: Chen, Z, et al.
Published: (1989)

PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS
by: Downs, J, et al.
Published: (1995)

Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study
by: Simes, R, et al.
Published: (2009)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
by: Collins, R, et al.
Published: (2002)

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control
by: Kearney, P, et al.
Published: (2006)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.
by: Wardle, J, et al.
Published: (1996)

Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus
by: Collins, R, et al.
Published: (2002)

Wider inclusion criteria needed for thrombolytic therapy.
by: Peto, R, et al.
Published: (1989)

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.
by: Clarke, R, et al.
Published: (2002)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
by: Collins, R, et al.
Published: (2004)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
by: Baigent, C, et al.
Published: (2010)

Blood pressure and coronary heart disease.
by: Collins, R, et al.
Published: (1990)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease
by: Collins, R, et al.
Published: (2002)

Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.
by: Collins, R, et al.
Published: (1988)

Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.
by: Chen, Z, et al.
Published: (1993)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
by: Baigent, C, et al.
Published: (2005)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
by: Emberson, J, et al.
Published: (2012)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
by: Baigent, C, et al.
Published: (2008)

A time of need: exploring the changing poverty risk facing larger families in the UK
by: Stewart, K, et al.
Published: (2023)

OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION
by: Sleight, P, et al.
Published: (1986)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)